These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26784857)

  • 21. Inactivation of spores by nonthermal plasmas.
    Puligundla P; Mok C
    World J Microbiol Biotechnol; 2018 Sep; 34(10):143. PubMed ID: 30203172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a sporicidal test method for Clostridium difficile.
    Fraise AP; Wilkinson MA; Bradley CR; Paton S; Walker J; Maillard JY; Wesgate RL; Hoffman P; Coia J; Woodall C; Fry C; Wilcox M
    J Hosp Infect; 2015 Jan; 89(1):2-15. PubMed ID: 25477061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivation of Clostridium difficile spore outgrowth by synergistic effects of nisin and lysozyme.
    Chai C; Lee KS; Imm GS; Kim YS; Oh SW
    Can J Microbiol; 2017 Jul; 63(7):638-643. PubMed ID: 28346844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolutionary clade affects resistance of Clostridium difficile spores to Cold Atmospheric Plasma.
    Connor M; Flynn PB; Fairley DJ; Marks N; Manesiotis P; Graham WG; Gilmore BF; McGrath JW
    Sci Rep; 2017 Feb; 7():41814. PubMed ID: 28155914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery.
    Chilton CH; Freeman J; Baines SD; Crowther GS; Nicholson S; Wilcox MH
    J Antimicrob Chemother; 2013 Sep; 68(9):2078-82. PubMed ID: 23759507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The search for new sporicidal agents for medical use: where are we?
    Piktel E; Pogoda K; Savage PB; Bucki R
    Future Microbiol; 2017 Jul; 12():735-737. PubMed ID: 28593804
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of the sporicidal activity of different chemical disinfectants used in hospitals against Clostridium difficile.
    Speight S; Moy A; Macken S; Chitnis R; Hoffman PN; Davies A; Bennett A; Walker JT
    J Hosp Infect; 2011 Sep; 79(1):18-22. PubMed ID: 21802172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Currently available sporicides for use in healthcare, and their limitations.
    Fraise A
    J Hosp Infect; 2011 Mar; 77(3):210-2. PubMed ID: 20850900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three novel highly charged copper-based biocides: safety and efficacy against healthcare-associated organisms.
    Gant VA; Wren MW; Rollins MS; Jeanes A; Hickok SS; Hall TJ
    J Antimicrob Chemother; 2007 Aug; 60(2):294-9. PubMed ID: 17567632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic efficacy of 405 nm light and chlorinated disinfectants for the enhanced decontamination of Clostridium difficile spores.
    Moorhead S; Maclean M; Coia JE; MacGregor SJ; Anderson JG
    Anaerobe; 2016 Feb; 37():72-7. PubMed ID: 26708703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antimicrobial properties of magnesium monoperoxyphthalate hexahydrate.
    Baldry MG
    J Appl Bacteriol; 1984 Dec; 57(3):499-503. PubMed ID: 6397460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival of Clostridium difficile spores at low water activity.
    Deng K; Talukdar PK; Sarker MR; Paredes-Sabja D; Torres JA
    Food Microbiol; 2017 Aug; 65():274-278. PubMed ID: 28400013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Updates on Clostridium difficile spore biology.
    Gil F; Lagos-Moraga S; Calderón-Romero P; Pizarro-Guajardo M; Paredes-Sabja D
    Anaerobe; 2017 Jun; 45():3-9. PubMed ID: 28254263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.
    Freeman J; Marquis M; Crowther GS; Todhunter SL; Fawley WN; Chilton CH; Moeck G; Lehoux D; Wilcox MH
    J Antimicrob Chemother; 2012 Dec; 67(12):2919-26. PubMed ID: 22899803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of natural products on several stages of the spore cycle of Clostridium difficile in vitro.
    Roshan N; Riley TV; Hammer KA
    J Appl Microbiol; 2018 Sep; 125(3):710-723. PubMed ID: 29675852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of hospital biocide sodium dichloroisocyanurate on the viability and properties of Clostridium difficile spores.
    Joshi LT; Welsch A; Hawkins J; Baillie L
    Lett Appl Microbiol; 2017 Sep; 65(3):199-205. PubMed ID: 28639362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of Sporicidal Activity for the Synergistic Combination of Peracetic Acid and Hydrogen Peroxide.
    Leggett MJ; Schwarz JS; Burke PA; McDonnell G; Denyer SP; Maillard JY
    Appl Environ Microbiol; 2016 Feb; 82(4):1035-1039. PubMed ID: 26637595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolating and Purifying Clostridium difficile Spores.
    Edwards AN; McBride SM
    Methods Mol Biol; 2016; 1476():117-28. PubMed ID: 27507337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of three disinfectants and acidified nitrite against Clostridium difficile spores.
    Wullt M; Odenholt I; Walder M
    Infect Control Hosp Epidemiol; 2003 Oct; 24(10):765-8. PubMed ID: 14587940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spore Resistance Properties.
    Setlow P
    Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 26104355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.